Evidence map›Paper›PMID 39092426›Full record

ArticleFrontiers in physiology2024

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation.

Arne van Hunnik, Vladimír Sobota, Stef Zeemering, Dragan Opacic, Billy Scaf, Elisa D'Alessandro, Karel Oyaert, Marion Kuiper, Jonas G Diness, Ulrik S Sørensen and 5 more

Abstract read
In one paragraph

Article in Frontiers in physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Role of interatrial connection ablation in re-entry dynamics: an in silico evaluation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Epicardial muscle bundles in persistent atrial fibrillation: from overlooked bystanders to arrhythmogenic modulators.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Review
  3. Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model.Circulation. Arrhythmia and electrophysiology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Arne van Hunnik *Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Vladimír Sobota *Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Stef ZeemeringDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Dragan OpacicDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Billy ScafDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Elisa D'AlessandroDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Karel OyaertDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Marion KuiperDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Jonas G DinessAcesion Pharma, Copenhagen, Denmark.
Ulrik S SørensenAcesion Pharma, Copenhagen, Denmark.
James T MilnesXention Ltd., Cambridge, United Kingdom.
Marcel A G van der HeydenDepartment of Medical Physiology, University Medical Center Utrecht, Utrecht, Netherlands.
Thomas JespersenDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Ulrich SchottenDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
Sander VerheuleDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The mechanisms leading to the conversion of atrial fibrillation (AF) to sinus rhythm are poorly understood. This study describes the dynamic behavior of electrophysiological parameters and conduction patterns leading to spontaneous and pharmacological AF termination. Methods: Five independent groups of goats were investigated: (1) spontaneous termination of AF, and drug-induced terminations of AF by various potassium channel inhibitors: (2) AP14145, (3) PA-6, (4) XAF-1407, and (5) vernakalant. Bi-atrial contact mapping was performed during an open chest surgery and intervals with continuous and discrete atrial activity were determined. AF cycle length (AFCL), conduction velocity and path length were calculated for each interval, and the final conduction pattern preceding AF termination was evaluated. Results: AF termination was preceded by a sudden episode of discrete activity both in the presence and absence of an antiarrhythmic drug. This episode was accompanied by substantial increases in AFCL and conduction velocity, resulting in prolongation of path length. In 77% ± 4% of all terminations the conduction pattern preceding AF termination involved medial to lateral conduction along Bachmann's bundle into both atria, followed by anterior to posterior conduction. This finding suggests conduction block in the interatrial septum and/or pulmonary vein area as final step of AF termination. Conclusion: AF termination is preceded by an increased organization of fibrillatory conduction. The termination itself is a sudden process with a critical role for the interplay between spatiotemporal organization and anatomical structure.

Indexed as

antiarrhythmic drugsatrial anatomyatrial fibrillationBachmann’s bundlecardioversion

Identifiers

PMID39092426
PMCPMC11291310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.